Beta blockers and chronic heart failure patients: prognostic impact of a dose targeted beta blocker therapy vs. heart rate targeted strategy.

Anna CorlettoHanna FröhlichTobias TägerMatthias HochadelRalf ZahnCaroline KilkowskiRalph WinklerJochen SengesHugo A KatusLutz Frankenstein

Published in: Clinical research in cardiology : official journal of the German Cardiac Society (2018)

Achieving guidelines recommended beta blocker dose or to HR control has a similar positive impact on survival. When on target dose, supplemental HR control additionally improves survival.

Keyphrases

heart rate
ejection fraction
end stage renal disease
angiotensin converting enzyme
heart rate variability
blood pressure
chronic kidney disease
newly diagnosed
cancer therapy
prognostic factors
peritoneal dialysis
stem cells
drug delivery
angiotensin ii
clinical practice
bone marrow
cell therapy
replacement therapy